NYSEARCA:MRNY YieldMax MRNA Option Income Strategy ETF (MRNY) Price, Holdings, & News $39.04 +0.21 (+0.54%) Closing price 04:10 PM EasternExtended Trading$39.27 +0.23 (+0.60%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsNews and TrendsShort Interest About YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MRNY alerts:Sign Up Key Stats Today's Range$38.38▼$40.4750-Day Range$14.22▼$42.0052-Week Range$13.60▼$42.39Volume576,644 shsAverage Volume240,955 shsMarket Capitalization$211.21 millionAssets Under Management$202.89 millionDividend Yield35.84%Net Expense Ratio1.00%Aggregate RatingN/A ETF Overview The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax. Read More YieldMax MRNA Option Income Strategy ETF ExpensesTypeMRNYSingle Stock ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.99%0.98%0.57%0.50%0.53%Other Expenses0.01%0.28%0.53%0.60%0.54%Total Expense1.00%1.19%0.75%0.75%0.73%Fee Waiver0.00%-0.43%-0.67%-0.78%-0.68%Net Expense1.00%1.07%0.63%0.57%0.60% Receive MRNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for YieldMax MRNA Option Income Strategy ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MRNY ETF News HeadlinesYieldMax MRNA Option Income Strategy ETF declares $0.6367 dividendSeptember 23 at 11:51 AM | seekingalpha.comYieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) Stock Price Up 5.1% - Still a Buy?September 23 at 2:01 AM | americanbankingnews.comCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.September 23 at 1:00 AM | Paradigm Press (Ad)YieldMax MRNA option income strategy ETF declares $0.5672 dividendSeptember 17, 2026 | msn.comThe Melanoma Win Is Real, The Price Isn't - Moderna And MRNY Both SellSeptember 14, 2026 | seekingalpha.comYieldMax MRNA option income strategy ETF announces weekly distribution of $0.6420September 10, 2026 | msn.comSee More Headlines MRNY ETF - Frequently Asked Questions How have MRNY shares performed this year? YieldMax MRNA Option Income Strategy ETF's stock was trading at $14.70 on January 1st, 2026. Since then, MRNY shares have increased by 165.6% and is now trading at $39.04. When did YieldMax MRNA Option Income Strategy ETF's stock split? YieldMax MRNA Option Income Strategy ETF shares reverse split on the morning of Monday, December 1st 2025.A 1-10 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, November 30th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of YieldMax MRNA Option Income Strategy ETF? Shares of MRNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of YieldMax MRNA Option Income Strategy ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that YieldMax MRNA Option Income Strategy ETF investors own include YieldMax NVDA Option Income Strategy ETF (NVDY), YieldMax COIN Option Income Strategy ETF (CONY), YieldMax META Option Income Strategy ETF (FBY), Defiance Nasdaq 100 Enhanced Options & 0DTE Income ETF (QQQY), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Oxford Lane Capital (OXLC) and YieldMax AMZN Option Income Strategy ETF (AMZY). Fund Details IssuerElevate Shares Fund NameYieldMax MRNA Option Income Strategy ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:MRNY Inception Date10/23/2023 Fund ManagerMick Brokaw, Jay Pestrichelli, Qiao Duan, Charles Ragauss WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusSingle Stock Development LevelDeveloped Markets RegionNorth America Number of Holdings16 Fund Statistics Assets Under Management$202.89 million Average Daily Volume$0.00 Discount/Premium0.22% Administrator, Advisor and Custodian AdministratorTidal ETF Services, LLC AdvisorTidal Investments, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerCitadel Options OptionableOptionable Options Volume123 Put Options26 Call Options97 Short Interest51,284 shs Miscellaneous Outstanding Shares5,410,000Beta0.14 Creation Fee$300.00 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report Top 10 MRNY HoldingsOTHER ASSETS AND LIABILITIESHolding Weight: 54.03%Mrna 11/20/2026 135.01 CHolding Weight: 30.23%United States Treasury Bills 0%Holding Weight: 21.45%First American Government Obligs XHolding Weight: 7.39%United States Treasury Bills 0%Holding Weight: 6.56%United States Treasury Notes 2.38%Holding Weight: 5.58%Cash OffsetHolding Weight: 2.05%MRNA US 09/18/26 C157.5Holding Weight: 0.95%MRNA US 09/18/26 C144Holding Weight: 0.88%MRNA US 09/18/26 C143Holding Weight: 0.87%Full Holdings DetailsMRNY Sector ExposureMRNY Geographic Exposure This page (NYSEARCA:MRNY) was last updated on 9/23/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YieldMax MRNA Option Income Strategy ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share YieldMax MRNA Option Income Strategy ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
